So-Young International Inc. reported unaudited Q4 2025 total revenues of RMB460.7 million, up 24.8% from RMB369.2 million in Q4 2024, driven by 205.3% growth in aesthetic treatment services revenues to RMB248.1 million, with net loss of RMB108.8 million versus RMB607.6 million prior year. FY2025 revenues reached RMB1,523.4 million with net loss of RMB242.3 million, and the company extended its US$25 million share repurchase program through March 31, 2027.
Key takeaways
Q4 2025 total revenues RMB460.7 million versus RMB369.2 million in Q4 2024
Q4 2025 aesthetic treatment services revenues RMB248.1 million versus RMB81.3 million in Q4 2024
Q4 2025 net loss attributable to So-Young RMB108.8 million versus RMB607.6 million in Q4 2024
FY2025 total revenues RMB1,523.4 million versus RMB1,466.7 million in FY2024
FY2025 net loss attributable to So-Young RMB242.3 million versus RMB589.5 million in FY2024
49 fully operational branded aesthetic centers as of December 31, 2025, with 25 achieving profitability in Q4
Share repurchase program extended through March 31, 2027; approximately 4.8 million ADSs repurchased in 2024 and 2025